Medicare Enrolled

Dr. Amir Salam, M.D.

Medical Oncology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
18100 HOUSTON METHODIST DR., MEDICAL OFFICE BUILDING 2, Houston, TX 77058
8327831190
In practice since 2010 (15 years)
NPI: 1346569316 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Salam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Salam

Dr. Amir Salam is a medical oncology specialist in Houston, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Salam performed 41,407 Medicare services across 708 unique beneficiaries.

Between the years covered by Open Payments, Dr. Salam received a total of $13,890 from 77 pharmaceutical and/or device companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Salam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 22% volume in TX $13,890 industry payments

Medicare Practice Summary

Medicare Utilization ↗
41,407
Medicare services
Top 22% in TX for medical oncology
708
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,760 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 39,270 $0 $2
Dexamethasone injection (steroid) 485 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 350 $1 $4
Complete blood count (CBC) with differential 290 $8 $24
Office visit, established patient (30-39 min) 214 $94 $395
Office visit, established patient (20-29 min) 128 $64 $279
Blood draw (venipuncture) 122 $8 $9
Office visit, established patient, complex (40-54 min) 91 $138 $556
Administration of chemotherapy into vein, 1 hour or less 83 $104 $419
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 82 $51 $206
Drug injection, under skin or into muscle 77 $11 $54
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 66 $22 $92
New patient office visit (45-59 min) 51 $117 $513
Injection of additional new drug or substance into vein 43 $12 $49
New patient office visit (30-44 min) 22 $60 $353
Telephone medical discussion with physician, 11-20 minutes 17 $68 $285
New patient office visit, complex (60-74 min) 16 $175 $683
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
95.2% high complexity
2.5% medium
2.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,890
Total received (2018-2024)
Avg $1,984/year across 7 years
Top 34% in TX for medical oncology
77
Companies
672
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,435 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$455 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,462
2023
$2,974
2022
$3,183
2021
$2,380
2020
$1,056
2019
$1,053
2018
$1,782

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,129
AstraZeneca Pharmaceuticals LP
$821
Novartis Pharmaceuticals Corporation
$767
Janssen Biotech, Inc.
$684
PFIZER INC.
$660
Celgene Corporation
$595
GlaxoSmithKline, LLC.
$553
Merck Sharp & Dohme Corporation
$526
Merck Sharp & Dohme LLC
$485
Amgen Inc.
$481
Pharmacyclics LLC, An AbbVie Company
$419
GENZYME CORPORATION
$376
Gilead Sciences, Inc.
$342
Boehringer Ingelheim Pharmaceuticals, Inc.
$342
Exelixis Inc.
$318
Seagen Inc.
$306
Incyte Corporation
$284
Lilly USA, LLC
$268
Rigel Pharmaceuticals, Inc.
$256
Daiichi Sankyo Inc.
$254
Sirtex Medical Inc
$202
Bayer HealthCare Pharmaceuticals Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$197
Genentech USA, Inc.
$173
Myovant Sciences Inc.
$164
Taiho Oncology, Inc.
$154
SpringWorks Therapeutics, Inc.
$152
Puma Biotechnology, Inc.
$150
AVEO Pharmaceuticals, Inc.
$143
CTI BioPharma Corp.
$127
BeiGene USA, Inc.
$126
ARRAY BIOPHARMA INC
$124
Astellas Pharma US Inc
$123
Janssen Pharmaceuticals, Inc
$117
PUMA BIOTECHNOLOGY, INC.
$114
Eisai Inc.
$112
MorphoSys, US Inc.
$95
AbbVie Inc.
$93
Deciphera Pharmaceuticals Inc.
$91
EISAI INC.
$90
EMD Serono, Inc.
$89
Foundation Medicine, Inc.
$78
Pharmacyclics LLC, an AbbVie Company
$76
Ipsen Biopharmaceuticals, Inc
$69
Alexion Pharmaceuticals, Inc.
$58
TerSera Therapeutics LLC
$57
TESARO, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$51
Tempus AI, Inc
$46
Bayer Healthcare Pharmaceuticals Inc.
$46
ABBVIE INC.
$44
Acceleron Pharma, Inc.
$42
AMAG Pharmaceuticals, Inc.
$40
Sobi, Inc
$37
Verastem, Inc.
$35
Mirati Therapeutics, Inc.
$31
Stemline Therapeutics Inc.
$29
Dova Pharmaceuticals
$29
Blueprint Medicines Corporation
$29
SOBI, INC
$29
Kite Pharma, Inc.
$27
Boston Scientific Corporation
$27
Secura Bio, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
Sumitomo Pharma America, Inc.
$22
Esperion Therapeutics, Inc.
$21
Lexicon Pharmaceuticals, Inc.
$21
EUSA Pharma (US) LLC
$18
Novo Nordisk Inc
$18
TAIHO ONCOLOGY, INC.
$18
Karyopharm Therapeutics Inc.
$15
Teva Pharmaceuticals USA, Inc.
$14
Servier Pharmaceuticals LLC
$14
United Therapeutics Corporation
$13
Seattle Genetics, Inc.
$12
Bioventus LLC
$12
IBSA Pharma Inc.
$11
Top 3 companies account for 19.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Aliqopa · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · Durolane · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NEXLETOL · NINLARO · NONE · Nexavar · Nplate · Nubeqa · OFEV · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PROMACTA · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tirosint · Tresiba · Trodelvy · Turalio · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $34 per 100 Medicare services performed
Looking for a medical oncology specialist in Houston?
Compare medical oncologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
168
Per 100K population
3.5
County median income
$73,104
Nearest hospital
HOUSTON METHODIST CLEAR LAKE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Salam is a mixed practice specialist, with above-average Medicare volume (top 22% in TX), with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Salam experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Salam performed 39,270 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salam receive payments from pharmaceutical companies?
Yes. Dr. Salam received a total of $13,890 from 77 companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salam's costs compare to other medical oncologists in Houston?
Dr. Salam's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →